F Lopez-Munoz

Summary

Affiliation: University of Alcal
Country: Spain

Publications

  1. ncbi Bibliometric analysis of biomedical publications on SSRI during 1980-2000
    Francisco López-Muñoz
    Department of Pharmacology, University of Alcala, Madrid, Spain
    Depress Anxiety 18:95-103. 2003
  2. doi A bibliometric study of international scientific productivity in attention-deficit hyperactivity disorder covering the period 1980-2005
    Francisco López-Muñoz
    Dept of Pharmacology, Faculty of Medicine, University of Alcala, C Juan Ignacio Luca de Tena 8, 28027 Madrid, Spain
    Eur Child Adolesc Psychiatry 17:381-91. 2008
  3. pmc Psychotropic drugs in the Cervantine texts
    Francisco López-Muñoz
    Department of Pharmacology, Neuropsychopharmacology Unit, University of Alcala, Madrid, Spain
    J R Soc Med 101:226-34. 2008
  4. ncbi "Than all the herbs described by Dioscorides...": the traces of Andrés Laguna in the works of Cervantes
    Francisco López-Muñoz
    Department of Pharmacology, Faculty of Medicine, University of Alcala, Madrid, Spain
    Pharm Hist 49:87-108. 2007
  5. ncbi [The development of neurotoxic agents as chemical weapons during the National Socialist period in Germany]
    F Lopez-Munoz
    Departamento de Farmacologia, Facultad de Medicina, Universidad de Alcalá Alcalá de Henares, Madrid, Espana
    Rev Neurol 47:99-106. 2008
  6. doi The role of psychopharmacology in the medical abuses of the Third Reich: from euthanasia programmes to human experimentation
    Francisco López-Muñoz
    Neuropsychopharmacology Unit, Department of Pharmacology, Faculty of Medicine, University of Alcala, Campus Universitario, Ctra Madrid Barcelona Km 33, 600, 28871 Alcala de Henares, Madrid, Spain
    Brain Res Bull 77:388-403. 2008
  7. doi The pharmaceutical industry and the German National Socialist Regime: I.G. Farben and pharmacological research
    F Lopez-Munoz
    Department of Pharmacology, Faculty of Medicine, University of Alcala, Madrid, Spain
    J Clin Pharm Ther 34:67-77. 2009
  8. ncbi The neurobiological interpretation of the mental functions in the work of Santiago Ramón y Cajal
    Francisco López-Muñoz
    University of Alcala, Madrid
    Hist Psychiatry 19:5-24. 2008
  9. doi The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice
    Francisco López-Muñoz
    Neuropsychopharmacology Unit, Department of Pharmacology, Faculty of Medicine, University of Alcala, Ctra Madrid Barcelona, Km 33600, Alcala de Henares, 29971 Madrid, Spain
    Brain Res Bull 79:130-41. 2009
  10. doi Historical evolution of the neurotransmission concept
    Francisco López-Muñoz
    Neuropsychopharmacology Unit, Department of Pharmacology, University of Alcala, Madrid, Spain
    J Neural Transm 116:515-33. 2009

Collaborators

Detail Information

Publications33

  1. ncbi Bibliometric analysis of biomedical publications on SSRI during 1980-2000
    Francisco López-Muñoz
    Department of Pharmacology, University of Alcala, Madrid, Spain
    Depress Anxiety 18:95-103. 2003
    ....
  2. doi A bibliometric study of international scientific productivity in attention-deficit hyperactivity disorder covering the period 1980-2005
    Francisco López-Muñoz
    Dept of Pharmacology, Faculty of Medicine, University of Alcala, C Juan Ignacio Luca de Tena 8, 28027 Madrid, Spain
    Eur Child Adolesc Psychiatry 17:381-91. 2008
    ..We have carried out a bibliometric analysis of scientific publications related to attention-deficit hyperactivity disorder (ADHD) and its pharmacological treatment over the period 1980-2005...
  3. pmc Psychotropic drugs in the Cervantine texts
    Francisco López-Muñoz
    Department of Pharmacology, Neuropsychopharmacology Unit, University of Alcala, Madrid, Spain
    J R Soc Med 101:226-34. 2008
  4. ncbi "Than all the herbs described by Dioscorides...": the traces of Andrés Laguna in the works of Cervantes
    Francisco López-Muñoz
    Department of Pharmacology, Faculty of Medicine, University of Alcala, Madrid, Spain
    Pharm Hist 49:87-108. 2007
  5. ncbi [The development of neurotoxic agents as chemical weapons during the National Socialist period in Germany]
    F Lopez-Munoz
    Departamento de Farmacologia, Facultad de Medicina, Universidad de Alcalá Alcalá de Henares, Madrid, Espana
    Rev Neurol 47:99-106. 2008
    ..Furthermore, successive National Socialist governments set up a collaborative network made up of the academia, the chemical industry and military chiefs that also favoured this line of research...
  6. doi The role of psychopharmacology in the medical abuses of the Third Reich: from euthanasia programmes to human experimentation
    Francisco López-Muñoz
    Neuropsychopharmacology Unit, Department of Pharmacology, Faculty of Medicine, University of Alcala, Campus Universitario, Ctra Madrid Barcelona Km 33, 600, 28871 Alcala de Henares, Madrid, Spain
    Brain Res Bull 77:388-403. 2008
    ....
  7. doi The pharmaceutical industry and the German National Socialist Regime: I.G. Farben and pharmacological research
    F Lopez-Munoz
    Department of Pharmacology, Faculty of Medicine, University of Alcala, Madrid, Spain
    J Clin Pharm Ther 34:67-77. 2009
    ..G. Farben brought to justice for, among other offences, the use of slave labour in the concentration camps and forced experimentation with drugs on prisoners...
  8. ncbi The neurobiological interpretation of the mental functions in the work of Santiago Ramón y Cajal
    Francisco López-Muñoz
    University of Alcala, Madrid
    Hist Psychiatry 19:5-24. 2008
    ..After being awarded the Nobel Prize in 1906, Cajal's interests in psychological aspects began to decline...
  9. doi The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice
    Francisco López-Muñoz
    Neuropsychopharmacology Unit, Department of Pharmacology, Faculty of Medicine, University of Alcala, Ctra Madrid Barcelona, Km 33600, Alcala de Henares, 29971 Madrid, Spain
    Brain Res Bull 79:130-41. 2009
    ..Haloperidol has been included in the World Health Organisation's list of essential medicines...
  10. doi Historical evolution of the neurotransmission concept
    Francisco López-Muñoz
    Neuropsychopharmacology Unit, Department of Pharmacology, University of Alcala, Madrid, Spain
    J Neural Transm 116:515-33. 2009
    ..Finally, we describe the process of the discovery of the different neurotransmitters and neuroreceptors, and analyse the new interpretations postulated in relation to the neurotransmission concept at the dawn of the twenty-first century...
  11. ncbi Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today
    Francisco López-Muñoz
    Neuropsychopharmacology Unit, Department of Pharmacology, Faculty of Medicine, University of Alcala, Madrid, Spain
    Curr Pharm Des 15:1563-86. 2009
    ....
  12. ncbi [The mad and the demented in the literary works of Cervantes: on Cervantes' sources of medical information about neuropsychiatry]
    F Lopez-Munoz
    Departamento de Farmacologia, Universidad de Alcala de Henares, 28871 Madrid, Espana
    Rev Neurol 46:489-501. 2008
    ....
  13. ncbi [The virtue of that precious balsam...: approach to Don Quixote from the psychopharmacological perspective]
    F Lopez-Munoz
    Departamento de Farmacologia, Facultad de Medicina, Universidad de Alcala, Madrid
    Actas Esp Psiquiatr 35:149-220. 2007
    ....
  14. ncbi Bipolar disorder as an emerging pathology in the scientific literature: a bibliometric approach
    Francisco López-Muñoz
    Department of Pharmacology, Faculty of Medicine, University of Alcala, Madrid, Spain
    J Affect Disord 92:161-70. 2006
    ..To carry out a bibliometric study on the scientific publications in relation to bipolar disorder...
  15. ncbi [Historical approach to reserpine discovery and its introduction in psychiatry]
    F Lopez-Munoz
    Departamento de Farmacologia, Facultad de Medicina, Universidad de Alcala, Madrid
    Actas Esp Psiquiatr 32:387-95. 2004
    ..Finally, the conclusion reached was that, although the clinical relevance of reserpine was not as evident and long lasting as chlorpromazine, its initial contribution to the treatment of schizophrenic patients was of maximum importance...
  16. ncbi History of the discovery and clinical introduction of chlorpromazine
    Francisco López-Muñoz
    Neuropsychopharmacology Unit, Department of Pharmacology, Faculty of Medicine, University of Alcala, Madrid, Spain
    Ann Clin Psychiatry 17:113-35. 2005
    ..The historical process of discovery and clinical introduction of chlorpromazine, one of the greatest advances of 20th century medicine and history of psychiatry, is analyzed...
  17. ncbi "The herbs that have the property of healing...,": the phytotherapy in Don Quixote
    Francisco López-Muñoz
    Department of Pharmacology, Faculty of Medicine, University of Alcala, C Juan Ignacio Luca de Tena 8, 28027 Madrid, Spain
    J Ethnopharmacol 106:429-41. 2006
    ..Also, we have examined the possible scientific influences, which might have inspired Cervantes in this field, mainly the work of Andrés Laguna (Dioscorides' Materia Medica)...
  18. ncbi [A century of barbiturates in neurology]
    F Lopez-Munoz
    Unidad de Neuropsicofarmacología, Departamento de Farmacologia, Universidad de Alcala, Madrid, Spain
    Rev Neurol 39:767-75. 2004
    ..Until the early 20th century, pharmacological treatments for neurological disorders were scarce and inefficient; only bromides stood out as sedating and antiepileptic agents...
  19. ncbi Reboxetine addition in patients with mirtazapine-resistant depression: a case series
    Francisco López-Muñoz
    Department of Pharmacology, Faculty of Medicine, University of Alcala, Madrid, Spain
    Clin Neuropharmacol 29:192-6. 2006
    ....
  20. ncbi Neuron theory, the cornerstone of neuroscience, on the centenary of the Nobel Prize award to Santiago Ramón y Cajal
    Francisco López-Muñoz
    Neuropsychopharmacology Unit, Department of Pharmacology, Faculty of Medicine, University of Alcala, C Juan Ignacio Luca de Tena 8, 28027 Madrid, Spain
    Brain Res Bull 70:391-405. 2006
    ..Today, no neuroscientific discipline could be understood without recourse to the concept of neuronal individuality and nervous transmission at a synaptic level, as basic units of the nervous system...
  21. ncbi Psychiatry and political-institutional abuse from the historical perspective: the ethical lessons of the Nuremberg Trial on their 60th anniversary
    Francisco López-Muñoz
    Neuropsychopharmacology Unit, Pharmacology Department, University of Alcala, Madrid, Spain
    Prog Neuropsychopharmacol Biol Psychiatry 31:791-806. 2007
    ..Various strategies can be used to combat such abuses, though it is uncertain how effective they are in preventing them...
  22. ncbi Reboxetine combination in treatment-resistant depression to selective serotonin reuptake inhibitors
    F Lopez-Munoz
    Pharmacology Department, Faculty of Medicine, University of Alcala, Madrid, Spain
    Pharmacopsychiatry 40:14-9. 2007
    ..Treatment-resistant depression is a relatively common clinical occurrence: between 60-70% of depressive patients fail to achieve total remission to the initial treatment with selective serotonin reuptake inhibitors (SSRI)...
  23. ncbi [Combination therapy with reboxetine for major depression patients who are partial or nonresponders to serotonin selective reuptake inhibitors]
    G Rubio
    Servicio de Psiquiatría Hospital Universitario La Paz, Madrid, Spain
    Actas Esp Psiquiatr 31:315-24. 2003
    ..Recent studies have confirmed the usefulness of the therapeutical combination of two antidepressants from different pharmacological families in patients with single drug therapy resistant depression...
  24. doi Phytotherapy and psychiatry: bibliometric study of the scientific literature from the last 20 years
    P Garcia-Garcia
    Department of Pharmacology, University of Alcala, C Juan Ignacio Luca de Tena 8, 28027 Madrid, Spain
    Phytomedicine 15:566-76. 2008
    ..935) and China (IPa=0.721). Productivity on medicinal plants in the psychiatry area increased during the period 1986-2006. Nevertheless, documents about therapeutic herbs in this medical field are still relatively few in number...
  25. ncbi [Differences in management of depression in Spain from psychiatric and primary care physician point of view]
    B Martín-Agueda
    Departamento de Farmacologia, Facultad de Medicina, Universidad de Alcala, Jesús Aprendiz 10C, 28007 Madrid
    Actas Esp Psiquiatr 35:89-98. 2007
    ..Given that depression is the most prevalent psychiatric disorder in our society, the current situation in pharmacotherapy of depression in Spain has been studied from the point of view of psychiatrists and general practitioners (GP)...
  26. doi A bibliometric study of the use of the classification and diagnostic systems in psychiatry over the last 25 years
    F Lopez-Munoz
    Neuropsychopharmacology Unit, Pharmacology Department, Faculty of Medicine, University of Alcala, Madrid
    Psychopathology 41:214-25. 2008
    ..Our purpose was to examine the use of classification and diagnostic systems in the field of psychiatry (CDSP) from a bibliometric perspective, over the period 1980-2005...
  27. doi Augmentation treatment with amisulpride in schizophrenic patients partially responsive to olanzapine
    J D Molina
    Acute In Patient Unit, Dr R Lafora Psychiatric Hospital, Madrid, Spain
    Pharmacopsychiatry 44:142-7. 2011
    ..The purpose of the present work was to evaluate the efficacy and safety of amisulpride augmentation in patients responding at least partially to olanzapine...
  28. ncbi [Therapeutic approach to epilepsy from the nutritional view: current status of dietary treatment]
    M Vicente-Hernández
    Departamento de Farmacologia, Universidad de Alcala, Madrid, Spain
    Neurologia 22:517-25. 2007
    ..However, controlled, randomized clinical trials with larger population samples are needed to confirm these results in order to achieve an optimum and individualized dietary treatment in refractory epilepsy...
  29. doi An historical view of the pineal gland and mental disorders
    F Lopez-Munoz
    Department of Pharmacology, Faculty of Medicine, University of Alcala, Madrid, Spain
    J Clin Neurosci 18:1028-37. 2011
    ....
  30. doi [The pineal gland as physical tool of the soul faculties: a persistent historical connection]
    F Lopez-Munoz
    Departamento de Farmacologia, Facultad de Medicina, Universidad de Alcala, Madrid, Espana
    Neurologia 27:161-8. 2012
    ..One of more known hypotheses on this subject was proposed by Descartes, for whom the soul would host in the pineal gland, a brain body with a special location that would adequately address the functionalism of the human body...
  31. ncbi Effectiveness and safety of eprosartan on pulse pressure for the treatment of hypertensive patients
    N R Robles
    Service of Nephrology, Hospital Infanta Cristina, Badajoz, Medical Department Juste S A Q F, Madrid, Spain
    Int J Clin Pract 59:478-84. 2005
    ..Eprosartan was a well-tolerated and an effective drug in reducing PP, SBP and DBP below the recommended levels in patients with mild-to-moderate essential hypertension, allowing a high therapeutic compliance...
  32. ncbi Cartesian theories on the passions, the pineal gland and the pathogenesis of affective disorders: an early forerunner
    F Lopez-Munoz
    Department of Pharmacology, Faculty of Medicine, University of Alcala, Madrid, Spain
    Psychol Med 41:449-51. 2011
    ..The recent development of a new pharmacological agent acting through melatonergic receptors (agomelatine) has confirmed the close link between the pineal gland and affective disorders...